切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (05) : 312 -316. doi: 10.3877/cma.j.issn.1674-0807.2020.05.010

所属专题: 文献

综述

乳腺组织定位标记夹在乳腺外科中的应用
王昭蕊1, 裴静1,()   
  1. 1. 230032 合肥,安徽医科大学第一附属医院乳腺外科
  • 收稿日期:2018-10-12 出版日期:2020-10-01
  • 通信作者: 裴静

Application of breast tissue marker clip in breast surgery

Zhaorui Wang1, Jing Pei1()   

  • Received:2018-10-12 Published:2020-10-01
  • Corresponding author: Jing Pei
引用本文:

王昭蕊, 裴静. 乳腺组织定位标记夹在乳腺外科中的应用[J/OL]. 中华乳腺病杂志(电子版), 2020, 14(05): 312-316.

Zhaorui Wang, Jing Pei. Application of breast tissue marker clip in breast surgery[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2020, 14(05): 312-316.

乳腺组织定位标记夹是一种可经皮穿刺并在乳腺病灶组织中放置、具有定位标记作用的含金属标志物,主要用于可疑小肿块及不可触及乳腺癌的标记、接受新辅助治疗的乳腺癌的标记、新辅助治疗前阳性淋巴结的标记以及指导随后的定位切除。相对于现阶段最常用的导丝定位技术,乳腺组织定位标记夹的应用是一种创新与补充,特别是对于穿刺活组织检查后影像学检查无法定位的乳腺癌以及新辅助治疗达到pCR或接近pCR的影像学阴性乳腺癌,其成为术前唯一能精确定位原发肿块位置的技术。但是,该技术仍存在放置后移位等问题,其安全性、临床效果以及适应证等有待进一步的深入研究。

图1 超声引导下置入乳腺肿块标记夹
图2 置入乳腺肿块的标记夹在超声下显影
图3 术前导丝定位乳腺肿瘤位置
图4 导丝引导下切除乳腺肿瘤
[1]
Desantis CE, Ma J, Goding AS, et al. Breast cancer statistics, 2017, racial disparity in mortality by state [J]. Ca Cancer J Clin, 2017, 67(6):439-448.
[2]
Yang Z, Zheng R, Zhang S, et al. Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013[J]. Chin J Cancer Res,2017,29(5):385-394.
[3]
Brenner RJ. Percutaneous removal of postbiopsy marking clip in the breast using stereotactic technique[J]. AJR Am J Roentgenol, 2001,176(2):417-419.
[4]
Fisher B. Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer[J]. Cancer,1969,24(6):1286-1289.
[5]
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med, 2002, 347(16):1227-1232.
[6]
Barentsz MW, van den Bosch MA, Veldhuis WB, et al. Radioactive seed localization for non-palpable breast cancer[J]. Br J Surg,2013,100(5):582-588.
[7]
Volders JH, Haloua MH, Krekel NM, et al. Current status of ultrasound-guided surgery in the treatment of breast cancer[J]. World J Clin Oncol,2016,7(1):44-53.
[8]
Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18[J]. J Clin Oncol, 1997, 16(7):2483-2493.
[9]
郑新宇.乳腺癌保乳手术切缘问题[J].中国实用外科杂志,2011,31(10):928-931.
[10]
Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence[J]. J Clin Oncol,2000,18(8):1668-1675.
[11]
Patel J, Jenkins S. A technique for marking oncological breast tissue specimens[J].Ann Med Surg (Lond), 2016,7:7-8.
[12]
Gray RJ, Pockaj BA, Garvey E, et al. Intraoperative margin management in breast-conserving surgery: a systematic review of the literature[J]. Ann Surg Oncol, 2018,25(1):18-27.
[13]
Rahusen FD, Taets van Amerongen AH, van Diest PJ, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins[J].J Surg Oncol,1999, 72(2):72-76.
[14]
Reedijk M, Hodgson N, Gohla G, et al. A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy[J].Am J Surg, 2012, 204(3):263-268.

URL    
[15]
Nurko J, Mancino AT, Whitacre E, et al. Surgical benefits conveyed by biopsy site marking system using ultrasound localization[J]. Am J Surg, 2005, 190(4):618-622.
[16]
Corsi F, Sorrentino L, Sartani A, et al. Localization of nonpalpable breast lesions with sonographically visible clip: optimizing tailored resection and clear margins[J]. Am J Surg,2015,209(6):950-958.
[17]
Baltzer PA, Benndorf M, Dietzel M, et al. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study[J]. AJR Am J Roentgenol,2010,194(6):1658-1663.
[18]
Mahoney MC, Newell MS. Breast intervention: how I do it[J]. Radiology, 2013, 268(1):12-24.

URL    
[19]
鲁伦博,孔德兴,谢叻,等. 磁共振成像引导下乳腺病灶定位与活组织检查[J/CD]. 中华乳腺病杂志(电子版), 2018, 12(2):110-112.
[20]
Hong MJ, Cha JH, Kim HH, et al. Second-look ultrasonography for MRI-detected suspicious breast lesions in patients with breast cancer[J]. Ultrasonography,2015,34(2):125-132.
[21]
Spick C, Baltzer PA. Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis[J]. Radiology, 2014, 273(2):401-409.

URL    
[22]
Thomassin-Naggara I, Lalonde L, David J, et al. A plea for the biopsy marker: how, why and why not clipping after breast biopsy?[J]. Breast Cancer Res Treat, 2012,132(3):881-893.
[23]
Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J]. Lancet,2014,384(9938):164-172.

URL    
[24]
Dash N,Chafin SH,Johnson RR.Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer[J]. Am J Roentgenol,1999,173(4):911-917.
[25]
Oh JL, Nguyen G, Whitman GJ, et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy[J]. Cancer, 2007,110(11):2420-2427.
[26]
Kumar A, Puri R, Gadgil PV, et al. Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla[J]. World J Surg,2012,36(7):1453-1459.

URL    
[27]
Fu JF,Chen HL,Yang J,et al.Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: a meta-analysis[J].PLoS One,2014,9(9):e105316.
[28]
Mamounas EP, Brown A, Anderson S, et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J]. J Clin Oncol,2005,23(12):2694-2702.
[29]
Pilewskie M, Morrow M. Axillary nodal management following neoadjuvant chemotherapy: a review[J]. JAMA Oncol,2017,3(4):549-555.
[30]
Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial[J]. JAMA,2013,310(14):1455-1461.
[31]
Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)[J]. Ann Surg,2016,263(4):802-807.
[32]
《乳腺癌新辅助化疗后的病理诊断专家共识》编写组. 乳腺癌新辅助化疗后的病理诊断专家共识[J]. 中华病理学杂志,2015, 44(4): 232-236.
[33]
Barentsz MW, Verkooijen HM, Pijnappel RM, et al. Sentinel lymph node localization with contrast-enhanced ultrasound and an I-125 seed: An ideal prospective development study[J]. Int J Surg, 2015, 14:1-6.
[34]
van Nijnatten TJA, Simons JM, Smidt ML, et al. A novel less-invasive approach for axillary staging after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer by combining radioactive iodine seed localization in the axilla with the sentinel node procedure (RISAS): a dutch prospective multicenter validation study[J]. Clin Breast Cancer,2017,17(5):399-402.
[35]
Rosen EL, Vo TT. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis[J]. Radiology, 2001, 218(2):510-516.
[36]
Esserman LE, Cura MA, Dacosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy[J]. Radiographics, 2004, 24(1):147-156.
[37]
Rüland AM, Hagemann F, Reinisch M, et al. Using a new marker clip system in breast cancer: Tumark Vision® clip-feasibility testing in everyday clinical practice[J]. Breast Care (Basel),2018,13(2):116-120.
[38]
Sakamoto N, Ogawa Y, Tsunoda Y, et al. Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip®) placed in phantoms and patients[J]. Breast Cancer, 2017, 24(4):585-592.
[39]
Carmon M, Olsha O, Gekhtman D, et al. Detectability of hygroscopic clips used in breast cancer surgery[J]. J Ultrasound Med,2017,36(2):401-408.
[40]
中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J].中国癌症杂志,2017,27(9):695-760.
[1] 马晓菊, 梁潇, 段云友, 袁丽君, 赵萍. NBAV脂质纳泡对ApoE -/-小鼠动脉粥样硬化病变的评估和干预[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 608-616.
[2] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[3] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[4] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[5] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[6] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[7] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[8] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[9] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[10] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[11] 王苏睿, 胡根, 邵国益. A 型肉毒杆菌毒素在腹腔开放后腹壁缺损修复中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 649-653.
[12] 袁园园, 岳乐淇, 张华兴, 武艳, 李全海. 间充质干细胞在呼吸系统疾病模型中肺组织分布及治疗机制的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 374-381.
[13] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[14] 王曦娅, 尹弘青, 丁伟, 徐滨, 于海源, 马东升, 邵军. 桥本背景下甲状腺乳头状癌多参数分析预测大容量淋巴结转移[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 548-554.
[15] 耿晓坤. 缺血性卒中后无效再灌注的时间窗、组织窗与神经保护[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(06): 636-636.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?